2Seventy Total Assets vs Current Deferred Revenue Analysis

TSVT Stock  USD 4.80  0.20  4.00%   
2Seventy Bio financial indicator trend analysis is way more than just evaluating 2Seventy Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 2Seventy Bio is a good investment. Please check the relationship between 2Seventy Bio Total Assets and its Current Deferred Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

Total Assets vs Current Deferred Revenue

Total Assets vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 2Seventy Bio Total Assets account and Current Deferred Revenue. At this time, the significance of the direction appears to have no relationship.
The correlation between 2Seventy Bio's Total Assets and Current Deferred Revenue is 0.06. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of 2Seventy Bio, assuming nothing else is changed. The correlation between historical values of 2Seventy Bio's Total Assets and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of 2Seventy Bio are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Assets i.e., 2Seventy Bio's Total Assets and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.06
Relationship DirectionPositive 
Relationship StrengthInsignificant

Total Assets

Total assets refers to the total amount of 2Seventy Bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in 2Seventy Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from 2Seventy Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 2Seventy Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.Selling General Administrative is likely to gain to about 86.4 M in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit52.0M65.3M73.2M70.4M
Total Revenue54.5M91.5M100.4M108.8M

2Seventy Bio fundamental ratios Correlations

0.570.7-0.85-0.840.63-0.860.740.480.48-0.64-0.650.680.270.720.850.640.59-0.820.60.7-0.560.040.840.40.63
0.570.99-0.18-0.570.99-0.830.960.950.06-0.96-0.830.980.920.970.430.990.93-0.511.00.99-0.980.250.860.960.99
0.70.99-0.32-0.650.99-0.90.980.930.15-0.96-0.840.990.860.990.540.990.93-0.610.991.0-0.960.210.920.920.99
-0.85-0.18-0.320.85-0.250.61-0.39-0.17-0.570.350.48-0.340.09-0.31-0.8-0.25-0.250.83-0.22-0.320.22-0.06-0.610.01-0.25
-0.84-0.57-0.650.85-0.630.81-0.69-0.59-0.290.690.85-0.68-0.34-0.6-0.78-0.6-0.670.83-0.58-0.650.58-0.09-0.82-0.36-0.63
0.630.990.99-0.25-0.63-0.850.980.940.04-0.96-0.870.980.890.970.461.00.95-0.540.990.99-0.970.230.870.931.0
-0.86-0.83-0.90.610.81-0.85-0.87-0.83-0.40.860.77-0.9-0.62-0.9-0.85-0.85-0.850.81-0.85-0.90.79-0.01-0.99-0.74-0.85
0.740.960.98-0.39-0.690.98-0.870.870.12-0.95-0.880.970.810.970.510.990.91-0.610.970.98-0.950.270.890.860.98
0.480.950.93-0.17-0.590.94-0.830.870.13-0.96-0.820.950.930.890.470.920.91-0.570.960.93-0.940.240.860.940.94
0.480.060.15-0.57-0.290.04-0.40.120.13-0.230.040.20.020.20.590.07-0.1-0.750.120.15-0.160.330.430.120.04
-0.64-0.96-0.960.350.69-0.960.86-0.95-0.96-0.230.88-0.99-0.9-0.93-0.51-0.96-0.880.69-0.97-0.960.98-0.39-0.91-0.91-0.96
-0.65-0.83-0.840.480.85-0.870.77-0.88-0.820.040.88-0.86-0.7-0.77-0.47-0.84-0.880.61-0.83-0.840.83-0.24-0.81-0.67-0.87
0.680.980.99-0.34-0.680.98-0.90.970.950.2-0.99-0.860.890.970.540.980.92-0.660.990.99-0.980.290.930.930.98
0.270.920.860.09-0.340.89-0.620.810.930.02-0.9-0.70.890.830.150.890.79-0.370.920.86-0.950.450.680.970.89
0.720.970.99-0.31-0.60.97-0.90.970.890.2-0.93-0.770.970.830.570.980.9-0.60.980.99-0.940.180.910.920.97
0.850.430.54-0.8-0.780.46-0.850.510.470.59-0.51-0.470.540.150.570.450.52-0.830.460.54-0.38-0.240.810.320.46
0.640.990.99-0.25-0.61.0-0.850.990.920.07-0.96-0.840.980.890.980.450.93-0.540.990.99-0.970.250.870.931.0
0.590.930.93-0.25-0.670.95-0.850.910.91-0.1-0.88-0.880.920.790.90.520.93-0.460.920.93-0.86-0.040.840.840.95
-0.82-0.51-0.610.830.83-0.540.81-0.61-0.57-0.750.690.61-0.66-0.37-0.6-0.83-0.54-0.46-0.56-0.610.58-0.34-0.85-0.43-0.54
0.61.00.99-0.22-0.580.99-0.850.970.960.12-0.97-0.830.990.920.980.460.990.92-0.560.99-0.980.280.880.960.99
0.70.991.0-0.32-0.650.99-0.90.980.930.15-0.96-0.840.990.860.990.540.990.93-0.610.99-0.960.210.920.920.99
-0.56-0.98-0.960.220.58-0.970.79-0.95-0.94-0.160.980.83-0.98-0.95-0.94-0.38-0.97-0.860.58-0.98-0.96-0.45-0.85-0.95-0.97
0.040.250.21-0.06-0.090.23-0.010.270.240.33-0.39-0.240.290.450.18-0.240.25-0.04-0.340.280.21-0.450.150.30.23
0.840.860.92-0.61-0.820.87-0.990.890.860.43-0.91-0.810.930.680.910.810.870.84-0.850.880.92-0.850.150.770.87
0.40.960.920.01-0.360.93-0.740.860.940.12-0.91-0.670.930.970.920.320.930.84-0.430.960.92-0.950.30.770.93
0.630.990.99-0.25-0.631.0-0.850.980.940.04-0.96-0.870.980.890.970.461.00.95-0.540.990.99-0.970.230.870.93
Click cells to compare fundamentals

2Seventy Bio Account Relationship Matchups

Pair Trading with 2Seventy Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 2Seventy Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 2Seventy Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against 2Seventy Stock

  0.59SLS Sellas Life SciencesPairCorr
  0.48MNMD Mind MedicineIncPairCorr
  0.48REVBW Revelation BiosciencesPairCorr
The ability to find closely correlated positions to 2Seventy Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 2Seventy Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 2Seventy Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 2Seventy Bio to buy it.
The correlation of 2Seventy Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 2Seventy Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 2Seventy Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 2Seventy Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether 2Seventy Bio is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if 2Seventy Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about 2seventy Bio Stock. Highlighted below are key reports to facilitate an investment decision about 2seventy Bio Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for 2Seventy Stock analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is 2Seventy Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 2Seventy Bio. If investors know 2Seventy will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 2Seventy Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.35)
Revenue Per Share
1.385
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.21)
Return On Equity
(0.73)
The market value of 2Seventy Bio is measured differently than its book value, which is the value of 2Seventy that is recorded on the company's balance sheet. Investors also form their own opinion of 2Seventy Bio's value that differs from its market value or its book value, called intrinsic value, which is 2Seventy Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 2Seventy Bio's market value can be influenced by many factors that don't directly affect 2Seventy Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 2Seventy Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 2Seventy Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 2Seventy Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.